FDA
approval
· 2022-12-13
FDA Approved: ZYNRELEF — Supplemental Application (Heron Therapeutics, Inc.)
Summary
FDA approved a supplemental application for ZYNRELEF (bupivacaine and meloxicam) from Heron Therapeutics, expanding its label/indication for postoperative pain …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZYNRELEF (BUPIVACAINE AND MELOXICAM)